Management of difficult inflammatory bowel disease: where are we now?

Podobne zapisy

• Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?
  od: Sang Hyoung Park
  Wydane: (2022-04-01)
• Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update
  od: Turkay, Cansel, i wsp.
  Wydane: (2010)
• Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
  od: Hasenoehrl, Carina, i wsp.
  Wydane: (2017)
• Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: Where are we now in the era of the next generation proteomics?
  od: Park, Jong-Min, i wsp.
  Wydane: (2014)
• Management of Indolent Lymphoma: Where Are We Now and Where Are We Going
  od: Lunning, Matthew, i wsp.
  Wydane: (2012)